↓ Skip to main content

Family planning and multiple sclerosis – part 2: Does real-world practice align with Swedish treatment guidelines?

Overview of attention for article published in Multiple Sclerosis Journal – Experimental, Translational and Clinical, July 2026
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
7 X users

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Family planning and multiple sclerosis – part 2: Does real-world practice align with Swedish treatment guidelines?
Published in
Multiple Sclerosis Journal – Experimental, Translational and Clinical, July 2026
DOI 10.1177/20552173261472249
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 1 33%
Unknown 2 67%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 1 33%
Unknown 2 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2026.
All research outputs
#10,701,748
of 34,394,870 outputs
Outputs from Multiple Sclerosis Journal – Experimental, Translational and Clinical
#214
of 531 outputs
Outputs of similar age
#71,696
of 342,995 outputs
Outputs of similar age from Multiple Sclerosis Journal – Experimental, Translational and Clinical
#2
of 20 outputs
Altmetric has tracked 34,394,870 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 531 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,995 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.